tiprankstipranks
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
US Market
Holding OPRX?
Track your performance easily

OptimizeRx (OPRX) Financial Statements

464 Followers

OptimizeRx Financial Overview

OptimizeRx's market cap is currently ―. The company's EPS TTM is $-1.325; its P/E ratio is -3.77; OptimizeRx is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $0.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 21.31M$ 18.81M$ 19.69M$ 28.37M$ 16.33M
Gross Profit$ 13.45M$ 11.70M$ 12.20M$ 17.84M$ 9.80M
EBIT$ -9.94M$ -5.10M$ -5.01M$ -8.21M$ -3.55M
EBITDA$ -8.66M$ -3.84M$ -3.76M$ -7.21M$ -3.09M
Net Income Common Stockholders$ -9.12M$ -4.01M$ -6.90M$ -4.14M$ -2.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.13M$ 0.00$ 0.00$ 13.85M$ 53.62M
Total Assets$ 165.20M$ 172.88M$ 176.37M$ 183.37M$ 123.93M
Total Debt$ 35.72M$ 36.09M$ 36.46M$ 36.82M$ 148.64K
Net Debt$ 19.59M$ 36.09M$ 36.46M$ 22.97M$ -53.47M
Total Liabilities$ 50.73M$ 51.86M$ 53.83M$ 56.82M$ 7.82M
Stockholders Equity$ 114.47M$ 121.02M$ 122.54M$ 126.55M$ 116.11M
Cash Flow-
Free Cash Flow$ 1.77M$ 737.00K$ 2.09M$ -5.48M$ 1.15M
Operating Cash Flow$ 1.79M$ 782.00K$ 2.12M$ -6.26M$ 1.47M
Investing Cash Flow$ -92.00K$ -85.00K$ -153.00K$ -26.00M$ -1.01M
Financing Cash Flow$ -532.00K$ -915.00K$ -640.00K$ 36.19M$ -349.43K
Currency in USD

OptimizeRx Earnings and Revenue History

OptimizeRx Debt to Assets

OptimizeRx Cash Flow

OptimizeRx Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis